Cargando…

Editorial: COVID-19 and hematological malignancies: Volume II

Detalles Bibliográficos
Autores principales:	Wilde, Lindsay, Binder, Adam, Cerchione, Claudio, Isidori, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589440/ https://www.ncbi.nlm.nih.gov/pubmed/36300086 http://dx.doi.org/10.3389/fonc.2022.1044582

Ejemplares similares

COVID-19 in Patients With Hematologic Malignancies: A Single Center Retrospective Study
por: Wang, Xuejun Alice, et al.
Publicado: (2021)

Editorial: The management of hematologic malignancies in lower-income countries
por: Ganesan, Prasanth, et al.
Publicado: (2023)

Editorial: Acute myeloid leukemia (AML): Is it time for MRD-driven treatment?
por: Guolo, Fabio, et al.
Publicado: (2022)

Treating Hematologic Malignancies During a Pandemic: Utilizing Telehealth and Digital Technology to Optimize Care
por: Binder, Adam F., et al.
Publicado: (2020)

Management of Patients With Hematologic Malignancies During the COVID-19 Pandemic: Practical Considerations and Lessons to Be Learned
por: Isidori, Alessandro, et al.
Publicado: (2020)

Editorial: Reviews in hematologic malignancies
por: Saraceni, Francesco, et al.
Publicado: (2022)

Editorial: Epidemiological trends in hematological malignancies
por: de Lima, Marcos, et al.
Publicado: (2023)

Editorial: Rising Stars in Hematologic Malignancies 2021
por: Qian, Liren, et al.
Publicado: (2022)

Editorial: Linking cellular metabolism to hematological malignancies
por: He, Xiujing, et al.
Publicado: (2022)

Editorial: Measurable residual disease in hematologic malignancies
por: Buccisano, Francesco, et al.
Publicado: (2023)

Editorial: Tumour microenvironment heterogeneity in hematological malignancies
por: Deaglio, Silvia, et al.
Publicado: (2023)

Editorial: Case reports in hematological malignancies: 2022
por: Antar, Ahmad, et al.
Publicado: (2023)

Caring for AML Patients During the COVID-19 Crisis: An American and Italian Experience
por: Wilde, Lindsay, et al.
Publicado: (2020)

Editorial: Deciphering the bone marrow microenvironment in hematologic malignancies
por: Wobus, Manja, et al.
Publicado: (2023)

Editorial: The Emerging Role for PP2A in Hematologic Malignancies
por: Ruvolo, Peter P.
Publicado: (2016)

Current Challenges in Hematology: Awareness, Prevention, Equity
por: Kaye, Dominic, et al.
Publicado: (2021)

Screening Strategies for COVID-19 in Patients With Hematologic Malignancies
por: Assi, Tarek, et al.
Publicado: (2020)

Editorial: Real-world data and real-world evidence in hematologic malignancies
por: Malagola, Michele, et al.
Publicado: (2023)

Cap-Independent Translation in Hematological Malignancies
por: Horvilleur, Emilie, et al.
Publicado: (2015)

Changing Management of Hematological Malignancies With COVID-19: Statement and Recommendations of the Lebanese Society of Hematology and Blood Transfusion
por: Ibrahim, Ahmad, et al.
Publicado: (2021)

Editorial: Biomarkers in genitourinary cancers: Volume II
por: Yuasa, Takeshi
Publicado: (2022)

Editorial: Characteristics and behaviors of hematopoietic stem cells and leukemia stem cells in hematologic malignancies
por: Zhang, Haojian, et al.
Publicado: (2022)

Editorial: Women in gastrointestinal cancers, volume II: 2022
por: Hamdy, Nadia M., et al.
Publicado: (2023)

Editorial: New emerging functions of transcription factors and RNA-binding proteins in the development of hematological malignancies
por: Möröy, Tarik, et al.
Publicado: (2023)

Case Report: Infectious prophylaxis in hematological malignancies
por: Passucci, Mauro, et al.
Publicado: (2023)

Semaphorins and Their Receptors in Hematological Malignancies
por: Wei, Li, et al.
Publicado: (2019)

WNT Signaling in Hematological Malignancies
por: Frenquelli, Michela, et al.
Publicado: (2020)

Checkpoint inhibition in hematologic malignancies
por: Tsumura, Aaron, et al.
Publicado: (2023)

Ferroptosis in hematological malignant tumors
por: Liu, Yong, et al.
Publicado: (2023)

COVID-19 in Patients with Hematologic Malignancies: A Single-Center Experience
por: Wilde, Lindsay, et al.
Publicado: (2020)

Editorial: Women in head and neck cancer, volume II: 2022
por: Economopoulou, Panagiota, et al.
Publicado: (2023)

Editorial: Women in molecular and cellular oncology, volume II: 2022
por: Dhar, Shilpa S.
Publicado: (2023)

Editorial: The Biological Landscape of Immunotherapy in AML
por: Isidori, Alessandro, et al.
Publicado: (2021)

The hedgehog pathway in hematopoiesis and hematological malignancy
por: Lemos, Tucker, et al.
Publicado: (2022)

Multiple Roles of Glycans in Hematological Malignancies
por: Pang, Xingchen, et al.
Publicado: (2018)

PHF6 Mutations in Hematologic Malignancies
por: Kurzer, Jason H., et al.
Publicado: (2021)

Editorial: Molecular advances in diagnosis and treatment of CNS tumors, volume II
por: Chen, Clark, et al.
Publicado: (2023)

Editorial: Women in cancer molecular targets and therapeutics, volume II: 2022
por: Berindan-Neagoe, Ioana, et al.
Publicado: (2023)

Editorial: CAR T-Cell Therapies in Hematologic Tumors
por: Coscia, Marta, et al.
Publicado: (2020)

Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview
por: Barbato, Alessandro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_52kgrn8qp2q2m7ri99dio66j37